contact us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right.​

         

123 Street Avenue, City Town, 99999

(123) 555-6789

email@address.com

 

You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.

ardenHEADERnew.png

Arden's Day Blog

Arden's Day is a type I diabetes care giver blog written by author Scott Benner. Scott has been a stay-at-home dad since 2000, he is the author of the award winning parenting memoir, 'Life Is Short, Laundry Is Eternal'. Arden's Day is an honest and transparent look at life with diabetes - since 2007.

type I diabetes, parent of type I child, diabetes Blog, OmniPod, DexCom, insulin pump, CGM, continuous glucose monitor, Arden, Arden's Day, Scott Benner, JDRF, diabetes, juvenile diabetes, daddy blog, blog, stay at home parent, DOC, twitter, Facebook, @ardensday, 504 plan, Life Is Short, Laundry Is Eternal, Dexcom SHARE, 生命是短暂的,洗衣是永恒的, Shēngmìng shì duǎnzàn de, xǐyī shì yǒnghéng de

Filtering by Category: DexCom Blog

Noninvasive BG monitoring with Apple Watch, "considered to be years away".

Scott Benner

There is a recent article circulating in the T1 community that in part reads, "Citing anonymous sources within Apple, reports in Bloomberg and the New York Times over the past weeks continue to add to the pile of leaks and rumors about two of Apple's currently under-development health devices: a wrist-worn glucose sensor and an EKG built into the Apple Watch."

The article goes on to call the glucose sensor a, "a noninvasive continuous glucose reader".

If you were to surf over to the New York Times link on the subject and read down you would see this...

Separately, Apple is continuing research on a noninvasive continuous glucose reader, according to two people with knowledge of the project. The technology is still considered to be years away, industry experts said.
— New York Times

"considered to be years away..."

That's pretty much it. I don't want to be a Debbie Downer and I'm certainly not a Negative Nancy but I didn't want you all to feel like this was coming with the next version of the Apple Watch. 

Now on to some good news...

I have a new giveaway for you to check out.


Dexcom Opens their API to Third-party Developers

Scott Benner

Dexcom leads the way in diabetes yet again...

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (CGM), announced today the availability of a public API, empowering third-party developers to connect patient-authorized CGM data into a broad range of software applications. This pioneering approach to CGM data sharing is intended to enable a rich ecosystem of novel solutions and put the user in control of where and how they interact with their glucose data.

"In launching this developer platform, Dexcom combines our CGM data expertise with the creativity of the developer ecosystem to enable new solutions and business models in the treatment and management of diabetes," said Annika Jimenez, Senior Vice President of Data, Dexcom. "Dexcom believes in data mobility and customer choice. It also believes that the API opens up opportunities to drive Dexcom CGM data into the heart of new digital solutions for payers, providers, and most importantly people with diabetes."

Get to it diabetes app developers, go make something great!

Dexcom Dev Page


New Apple Ad features Dexcom: Here is why that is important to you

Scott Benner

"my daughter was recently diagnosed with type 1 diabetes"

People living with T1D are understandably excited to hear the words, "my daughter was recently diagnosed with type 1 diabetes" in an Apple ad... but that is just the beginning of why this Apple Watch advertisement should get your heart pumping.

People reach out to Apple all the time to say how Apple Watch is helping them live healthier lives. Here, real customers read the actual stories they shared. Learn more: https://www.apple.com/apple-watch-series-3

The percentage of people with type 1 using continuous glucose monitoring technology is still relatively low. The barriers to adoption are multivariable. Cost, lack of insurance coverage, misunderstanding of what the technology brings to your life and plain just not knowing that it exists are but a few. The truth however is that even if you never find your way to a CGM this quick video, in my opinion, should still make you happy. Here's why.

We finally have a device manufacturer in the diabetes world who moved beyond the diabetes world. When Dexcom searched for others whose collaboration might improve their product, they didn't just form a relationship with a little start-up. They formed a relationship with Apple. The mention of Apple Watch integration with Dexcom in this ad, in my opinion, is not random. The mention didn't happen just because someone wrote a letter. It is there on purpose. This is Apple telling us what is important to them and a signal of where they are focusing their efforts when it comes to the health space. 

The company that put a smartphone into most every hand on the plant and the company that is hugely responsible for the technology that keeps my daughter healthy, they are dating. I think we are all going to like what their future children grow up to be. I'm even more excited when I think about the relationship that Dexcom has with Omnipod and the ways that the Apple connection could improve all aspects of the tech that helps to keep Arden's BGs where we want them. 

For the moment its great to hear diabetes in the mainstream in such a positive way, but I think that this is only the beginning of how Dexcom and Apple are going to make us smile. It is important to note that Dexcom advertises on the Juicebox Podcast but that I wrote this piece on my own. 


Dexcom Announces FDA Approval of G5 Mobile App for Android Devices

Scott Benner

FINALLY!!!!!!

Rejoice Android users..... rejoice!

from Dexcom.com

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce the Food and Drug Administration (FDA) approval of the Dexcom G5 mobile app for Android devices. Beginning in June, Android users will have access to the free app for the Dexcom G5 Mobile CGM System, allowing people with diabetes to view and monitor their glucose levels on their mobile devices to manage their diabetes in real time. The Dexcom G5 Mobile CGM System is the first and only CGM platform available for Android in the United States, complementing the 2015 iOS launch.

Download for free at the Google Play store here: bit.ly/AndroidDexcomG5MobileApp

The Dexcom G5 Mobile is a compact CGM system that works to display real-time glucose activity on certain approved display devices. The launch of Dexcom G5 Mobile for Android allows people to manage their diabetes in a more personal and discrete way by providing glucose data on their Android mobile device, as well as the ability to share it safely and conveniently. This empowers them to make informed and timely decisions about their diabetes, resulting in better health outcomes.

"Providing Android users with access to the Dexcom G5 Mobile CGM System has been a priority for Dexcom," said Kevin Sayer, President and CEO, Dexcom. "The new Android app has been thoughtfully designed with customer needs and feedback in mind. It focuses on delivering technology that empowers users by putting critical glucose information on their phones and is compatible with the most popular Android devices currently in the market."

Once commercially available, the new app will make the Dexcom G5 Mobile available on millions of additional phones in the United States. The Dexcom G5 Mobile app for Android will initially be available on several Android devices from Samsung, Motorola and LG, as well as Android Wear watches.

A current list of compatible devices can be found at www.dexcom.com/compatibility.